Stockscreener 앱 받기
3.445
4.39%
0.145
Abcellera Biologics Inc 주식(ABCL)의 최신 뉴스
Aug Big Picture: What is AbCellera Biologics Incs P E ratio telling usTrade Ideas & Accurate Buy Signal Notifications - baoquankhu1.vn
Insider Stock Buying Reaches US$1.04m On AbCellera Biologics - moomoo.com
AbCellera (ABCL): Among the stocks that could 10x over the next 5 years - MSN
Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Announces Target Price $3.52 - moomoo.com
What sparked AbCellera Biologics to soar over 9% after hours - MSN
AbCellera Biologics Inc. (ABCL) stock price, news, quote and history - Yahoo Finance UK
AbCellera Biologics Inc. (ABCL) Stock Price, News, Quote & History - Yahoo! Finance Canada
AbCellera (ABCL): Among the Stocks That Could 10x Over the Next 5 Years - Insider Monkey
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 - PharmiWeb.com
Press Release: AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026 - 富途牛牛
5 Stocks That Could 10X Over the Next 5 Years - Insider Monkey
Aug Gainers: Why is AbCellera Biologics Inc stock going down2026 Final Week & AI Driven Stock Reports - baoquankhu1.vn
ABCL SEC FilingsAbcellera Biologics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Update Report: What is AbCellera Biologics Incs P E ratio telling usTrade Signal Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn
Tudor Investment Corp ET AL Makes New Investment in AbCellera Biologics Inc. $ABCL - MarketBeat
AbCellera: Dart-Board Approach Reflects Trading Premium (Upgrade) (NASDAQ:ABCL) - Seeking Alpha
Sentiment Watch: What hedge funds are buying AbCellera Biologics IncEarnings Overview Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
AbCellera Biologics (ABCL) Goldman Sachs 45th Annual Global Healthcare Conference summary - Quartr
AbCellera Biologics Inc. (ABCL) - minichart.com.sg
Aug Intraday: Is AbCellera Biologics Inc affected by consumer sentiment - baoquankhu1.vn
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum - MarketBeat
Is AbCellera Biologics Inc a potential multi bagger2026 Sector Moves & Smart Money Movement Tracker - baoquankhu1.vn
Bear Alert: Is AbCellera Biologics Inc part of any ETF2026 Key Lessons & AI Optimized Trading Strategy Guides - baoquankhu1.vn
AbCellera at KeyBanc Forum: Strategic Advances in Biotech By Investing.com - Investing.com Canada
New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)’s Push Into Immunology and Beyond - MSN
AbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Rating of "Hold" from Analysts - MarketBeat
AbCellera Biologics Q1 2025 Earnings Preview - MSN
AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says - MarketBeat
AbCellera at TD Cowen Conference: Strategic Pipeline Insights By Investing.com - Investing.com Canada
DNB Asset Management AS Buys Shares of 656,208 AbCellera Biologics Inc. $ABCL - MarketBeat
Holdings Thermopylae Increases Stake in AbCellera Biologics Inc - GuruFocus
Thermopylae adds AbCellera (ABCL) shares in open-market buy - Stock Titan
AbCellera (ABCL) Is Up 18.8% After Pivoting To Clinical Stage And Filing Share Offering - simplywall.st
Thermopylae Holdings adds AbCellera (ABCL) shares in $3.27 open-market buy - Stock Titan
A Look At AbCellera Biologics (ABCL) Valuation After Narrower Losses And Pipeline Progress - simplywall.st
Decoding AbCellera Biologics Inc (ABCL): A Strategic SWOT Insigh - GuruFocus
Why AbCellera (ABCL) Is Up 11.5% After Narrowing Losses And Expanding ESOP Share Capacity – And What's Next - Yahoo Finance
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M - Insider Monkey
2.27%
1.21%
자본화:
|
볼륨(24시간):